Autoantibody to scaffold attachment factor B (SAFB): A novel connective tissue disease-related autoantibody associated with interstitial lung disease.

[1]  M. Hudson,et al.  Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects , 2014, The Journal of Rheumatology.

[2]  M. Fujimoto,et al.  Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement , 2014, Arthritis care & research.

[3]  T. Mimori,et al.  The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia , 2014, PloS one.

[4]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[5]  M. Fujimoto,et al.  Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome , 2013, PloS one.

[6]  M. Strek,et al.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. , 2013, Chest.

[7]  S. West,et al.  Connective tissue disease-associated interstitial lung disease: a call for clarification. , 2010, Chest.

[8]  Steffi Oesterreich,et al.  Low SAFB levels are associated with worse outcome in breast cancer patients , 2010, Breast Cancer Research and Treatment.

[9]  C. Weinberg,et al.  Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. , 2009, Arthritis and rheumatism.

[10]  R. Domsic,et al.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. , 2009, Arthritis and rheumatism.

[11]  T. Fujita,et al.  RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. , 2009, Arthritis and rheumatism.

[12]  Adrian V. Lee,et al.  Scaffold Attachment Factor B1 Functions in Development, Growth, and Reproduction , 2005, Molecular and Cellular Biology.

[13]  S. Okada,et al.  Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. , 2003, Arthritis and rheumatism.

[14]  Y. Ikeda,et al.  Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases , 2002, Annals of the rheumatic diseases.

[15]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[16]  R. Sontheimer.  Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? , 2002, Journal of the American Academy of Dermatology.

[17]  Adrian V. Lee,et al.  High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer , 2001, British Journal of Cancer.

[18]  C. Osborne,et al.  HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  R. Scorza,et al.  Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. , 1999, Clinical and experimental rheumatology.

[20]  A. Hartmann,et al.  SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. , 1998, Nucleic acids research.

[21]  Adrian V. Lee,et al.  Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells , 1997, Journal of cellular biochemistry.

[22]  V. Steen.  Autoantibodies in systemic sclerosis. , 1996, Seminars in arthritis and rheumatism.

[23]  S. Abe,et al.  Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. , 1995, American journal of respiratory and critical care medicine.

[24]  T. Medsger,et al.  Severe restrictive lung disease in systemic sclerosis. , 1994, Arthritis and rheumatism.

[25]  I. Targoff.  Autoantibodies in polymyositis. , 1992, Rheumatic diseases clinics of North America.

[26]  T. Medsger,et al.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.

[27]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[28]  T. Medsger,et al.  Factors predicting development of renal involvement in progressive systemic sclerosis. , 1984, The American journal of medicine.

[29]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[30]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[31]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[32]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[33]  H. Abrams,et al.  Alimentary tract in disseminated scleroderma with emphasis on small bowel. , 1954, A.M.A. archives of internal medicine.

[34]  M. Fujimoto,et al.  OnlineOpen: This article is available free online at www.blackwell-synergy.com Summary Correspondence , 2007 .

[35]  M. Fujimoto,et al.  Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. , 2007, Rheumatology.

[36]  T. Medsger,et al.  A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. , 2003, Arthritis and rheumatism.

[37]  F. O. Fackelmayer,et al.  Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA. , 1996, Nucleic acids research.

[38]  M. Kuwana,et al.  Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. , 1994, Arthritis and rheumatism.